News

In a recent randomised controlled trial, a whole-food, plant-based diet and exercise intervention was superior to standard medical care in improving glycaemic control, promoted diabetes remission and reduced...

A new consensus report offers key insights from over 6,000 articles on diabetic ketoacidosis and hyperglycaemic hyperosmolar state published since the previous 2009 consensus statement. Here we summarise how...

Cardiologists are increasingly interested in advances in diabetology, especially the latest drug classes, reports Tina Vilsbøll from a joint session of the European Association for the Study of Diabet...

The global burden of diabetes is continually growing, which calls for enhanced collective action to prevent and treat diabetes complications. The Sri Lanka College of Endocrinology, the European Association ...

The FLOW trial brought GLP-1 receptor agonists (GLP-1 RAs) to the forefront of the discussion about chronic kidney disease and type 2 diabetes. A new subanalysis now sheds light on the concomitant use of GLP...

The recently published Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD) was a joint effort of the European Association for the Study of the Liver (EASL), the E...

People living with diabetes have to make hundreds of decisions each day to manage their disease. Diabetes technology promises to ease this burden, but how effective is it in practice? This was one of the que...

Artificial intelligence is going to revolutionise also the medical field, especially when it comes to harnessing existing data sets for practical applications. A Swedish consortium has now published its appr...

The final day of the 84th ADA Scientific Sessions has arrived. In our final Newsflash episode, Alice Cheng reviews major advances and discoveries in diabetes in the year gone by.

Incretin-based therapies are our focus in the Day 3 Newsflash from the 84th ADA Scientific Sessions. Ildiko Lingvay discusses their role in preventing the progression from prediabetes to diabetes. Michael Na...

A priority to focus on in people with newly diagnosed type 2 diabetes is remission, says Roy Taylor in the Newsflash from Day 2 of the ADA Scientific Sessions, emphasising the current international consensus.

The EASD e-Learning Newsflash is back, bringing you highlights from the 84th ADA Scientific Session.

While obesity is regarded a major risk factor for the development of type 2 diabetes, the causality of the association remains debated. With current therapies targeting both obesity and diabetes, the exchang...

Metformin is typically taken with meals to reduce gastrointestinal side effects. However, recent data indicate that administering metformin before meals can improve glycaemic control and that this is linked ...

New research suggests that hypoglycaemia during sleep may have been underestimated by up to 30% in previous studies. The results were obtained by using continuous glucose monitoring (CGM) in addition to cust...

More than half of all men with diabetes have impaired sexual health, most commonly due to erectile dysfunction. In women with diabetes, sexual dysfunction is less prevalent, but still occurs. In a joint sess...

Challenges for people with t1d doing sports and access to diabetes tech in lower income countries were some of the focus topics on the final day of ATTD2024. Julia Mader sums up her impressions from the conf...

We focus on Chantal Mathieu’s update on CGM derived data in weekly insulins in our newsflash from #ATTD2024 Day 3. Another standout moment for us was the EUDF joint session. It explored how artificial intell...

Day 2 of ATTD 2024 came with updates on hypoglycaemia with Prof Pratik Choudhary and the unveiling of new monitoring guidance for presymptomatic type 1 diabetes with Co-Ch...

Highlights from Day1 of the 17th Conference on Advanced Technologies and Treatments for Diabetes with Prof Melanie Davies and Renza Scibilia.

Determining which treatment is suited best for specific patient groups can be a complex challenge. A recent study proposes a simple roadmap to guide clinicians through the interpretation of subgroup meta-ana...